Login / Signup

GFRAL-expressing neurons suppress food intake via aversive pathways.

Paul V SabatiniHenriette Frikke-SchmidtJoe ArthursDesiree GordianAnita R PatelAlan C RuppJessica M AdamsJine WangSebastian Beck JørgensenDavid P OlsonRichard D PalmiterMartin G MyersRandy J Seeley
Published in: Proceedings of the National Academy of Sciences of the United States of America (2021)
The TGFβ cytokine family member, GDF-15, reduces food intake and body weight and represents a potential treatment for obesity. Because the brainstem-restricted expression pattern of its receptor, GDNF Family Receptor α-like (GFRAL), presents an exciting opportunity to understand mechanisms of action for area postrema neurons in food intake; we generated Gfral Cre and conditional Gfral CreERT mice to visualize and manipulate GFRAL neurons. We found infection or pathophysiologic states (rather than meal ingestion) stimulate GFRAL neurons. TRAP-Seq analysis of GFRAL neurons revealed their expression of a wide range of neurotransmitters and neuropeptides. Artificially activating Gfral Cre -expressing neurons inhibited feeding, decreased gastric emptying, and promoted a conditioned taste aversion (CTA). GFRAL neurons most strongly innervate the parabrachial nucleus (PBN), where they target CGRP-expressing (CGRPPBN) neurons. Silencing CGRPPBN neurons abrogated the aversive and anorexic effects of GDF-15. These findings suggest that GFRAL neurons link non-meal-associated pathophysiologic signals to suppress nutrient uptake and absorption.
Keyphrases
  • spinal cord
  • poor prognosis
  • body weight
  • type diabetes
  • metabolic syndrome
  • high fat diet induced
  • risk assessment
  • weight loss
  • epithelial mesenchymal transition
  • climate change